Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
SciPlay price target raised to $25 from $23 at Macquarie » 08:56
03/02/21
03/02
08:56
03/02/21
08:56
SCPL

SciPlay

$19.28 /

+1.07 (+5.88%)

, GLUU

Glu Mobile

$12.58 /

+0.11 (+0.88%)

Macquarie analyst Chad…

Macquarie analyst Chad Beynon raised the firm's price target on SciPlay (SCPL) to $25 from $23 and keeps an Outperform rating on the shares. The company posted 30% revenue growth in Q4, benefitting from shelter-in-place orders but also exceeding industry trends as it focused on payer conversion ratios, Beynon tells investors in a research note. The analyst believes the Playika initial public offering and Glu Mobile (GLUU) sale bode well for SciPlay's valuation.

ShowHide Related Items >><<
SCPL SciPlay
$19.28 /

+1.07 (+5.88%)

GLUU Glu Mobile
$12.58 /

+0.11 (+0.88%)

SCPL SciPlay
$19.28 /

+1.07 (+5.88%)

02/18/21 Deutsche Bank
SciPlay price target raised to $23 from $20 at Deutsche Bank
02/17/21 BofA
SciPlay double-downgraded to Underperform from Buy at BofA
12/22/20 Morgan Stanley
SciPlay price target raised to $16 from $15 at Morgan Stanley
12/16/20 JPMorgan
SciPlay downgraded to Neutral on tough comps at JPMorgan
GLUU Glu Mobile
$12.58 /

+0.11 (+0.88%)

02/16/21 KeyBanc
Glu Mobile downgraded to Sector Weight from Overweight at KeyBanc
02/11/21 Benchmark
Glu Mobile downgraded to Hold from Buy at Benchmark
02/10/21 Roth Capital
Glu Mobile downgraded to Neutral from Buy at Roth Capital
02/10/21 Cowen
Glu Mobile downgraded to Market Perform from Outperform at Cowen
SCPL SciPlay
$19.28 /

+1.07 (+5.88%)

GLUU Glu Mobile
$12.58 /

+0.11 (+0.88%)

  • 04
    Jun
SCPL SciPlay
$19.28 /

+1.07 (+5.88%)

GLUU Glu Mobile
$12.58 /

+0.11 (+0.88%)

GLUU Glu Mobile
$12.58 /

+0.11 (+0.88%)

On The Fly
Fly Intel: After-Hours Movers » 18:59
03/01/21
03/01
18:59
03/01/21
18:59
INO

Inovio

$11.64 /

+0.52 (+4.68%)

, ASLN

Aslan Pharmaceuticals

$5.22 /

+0.82 (+18.64%)

, TTEC

TTEC Holdings

$88.80 /

+4.49 (+5.33%)

, ZM

Zoom Video

$409.67 /

+35.805 (+9.58%)

, HLIO

Helios Technologies

$67.14 /

+1.295 (+1.97%)

, AMRC

Ameresco

$60.46 /

+3.18 (+5.55%)

, TMDX

TransMedics

$36.30 /

+0.33 (+0.92%)

, MREO

Mereo BioPharma

$3.96 /

+0.07 (+1.80%)

, ROKU

Roku

$420.23 /

+25.095 (+6.35%)

, NLSN

Nielsen

$23.15 /

+0.73 (+3.26%)

, FGEN

FibroGen

$50.35 /

+0.38 (+0.76%)

, AI

C3.ai

$120.78 /

+8.41 (+7.48%)

, INSG

Inseego

$15.00 /

+0.35 (+2.39%)

, LMND

Lemonade

$132.23 /

+6.5 (+5.17%)

, MORF

Morphic

$84.57 /

+48.64 (+135.37%)

, SCPL

SciPlay

$19.28 /

+1.07 (+5.88%)

, NIO

NIO

$49.79 /

+3.08 (+6.59%)

, SWCH

Switch

$17.69 /

+0.33 (+1.90%)

, NVAX

Novavax

$239.73 /

+8.52 (+3.68%)

, SRPT

Sarepta

$86.94 /

-0.07 (-0.08%)

, SILK

Silk Road Medical

$55.35 /

+0.53 (+0.97%)

, OSUR

OraSure

$11.08 /

+0.42 (+3.94%)

, APPF

AppFolio

$160.72 /

-4.985 (-3.01%)

, SGMS

Scientific Games

$50.79 /

+3.84 (+8.18%)

, MELI

MercadoLibre

$1,715.90 /

+80.81 (+4.94%)

, RDHL

RedHill Biopharma

$9.19 /

-0.33 (-3.47%)

, COHU

Cohu

$46.01 /

+2.46 (+5.65%)

, BYND

Beyond Meat

$147.09 /

+1.7 (+1.17%)

Check out this evening's…

ShowHide Related Items >><<
ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

TTEC TTEC Holdings
$88.80 /

+4.49 (+5.33%)

TMDX TransMedics
$36.30 /

+0.33 (+0.92%)

SWCH Switch
$17.69 /

+0.33 (+1.90%)

SRPT Sarepta
$86.94 /

-0.07 (-0.08%)

SILK Silk Road Medical
$55.35 /

+0.53 (+0.97%)

SGMS Scientific Games
$50.79 /

+3.84 (+8.18%)

SCPL SciPlay
$19.28 /

+1.07 (+5.88%)

ROKU Roku
$420.23 /

+25.095 (+6.35%)

RDHL RedHill Biopharma
$9.19 /

-0.33 (-3.47%)

OSUR OraSure
$11.08 /

+0.42 (+3.94%)

NVAX Novavax
$239.73 /

+8.52 (+3.68%)

NLSN Nielsen
$23.15 /

+0.73 (+3.26%)

NIO NIO
$49.79 /

+3.08 (+6.59%)

MREO Mereo BioPharma
$3.96 /

+0.07 (+1.80%)

MORF Morphic
$84.57 /

+48.64 (+135.37%)

MELI MercadoLibre
$1,715.90 /

+80.81 (+4.94%)

LMND Lemonade
$132.23 /

+6.5 (+5.17%)

INSG Inseego
$15.00 /

+0.35 (+2.39%)

INO Inovio
$11.64 /

+0.52 (+4.68%)

HLIO Helios Technologies
$67.14 /

+1.295 (+1.97%)

FGEN FibroGen
$50.35 /

+0.38 (+0.76%)

COHU Cohu
$46.01 /

+2.46 (+5.65%)

BYND Beyond Meat
$147.09 /

+1.7 (+1.17%)

ASLN Aslan Pharmaceuticals
$5.22 /

+0.82 (+18.64%)

APPF AppFolio
$160.72 /

-4.985 (-3.01%)

AMRC Ameresco
$60.46 /

+3.18 (+5.55%)

AI C3.ai
$120.78 /

+8.41 (+7.48%)

INO Inovio
$11.64 /

+0.52 (+4.68%)

02/11/21 Oppenheimer
Opco starts DNA medicines 'disruptor' Inovio with buy, $35 price target
02/11/21 Oppenheimer
Inovio initiated with an Outperform at Oppenheimer
02/09/21 Maxim
Heat data puts cancer vaccine discussion 'back on the table,' says Maxim
01/08/21 Benchmark
Inovio price target lowered to $15 from $25 at Benchmark
ASLN Aslan Pharmaceuticals
$5.22 /

+0.82 (+18.64%)

03/01/21 Piper Sandler
Piper boosts Aslan target to $10 after positive atopic dematitis data
04/13/20 Piper Sandler
Aslan interim data for ASLN004 study still expected in 2020, says Piper Sandler
03/18/20 Piper Sandler
Aslan Pharmaceuticals price target lowered to $6 from $8 at Piper Sandler
TTEC TTEC Holdings
$88.80 /

+4.49 (+5.33%)

12/17/20 Canaccord
TTEC Holdings price target raised to $90 from $77 at Canaccord
10/15/20 Canaccord
TTEC Holdings model steadily shifts to digital, Canaccord starts with a Buy
10/15/20 Canaccord
TTEC Holdings initiated with a Buy at Canaccord
08/10/20
Fly Intel: Top five analyst downgrades
ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

01/26/21 MKM Partners
Fiverr downgraded to Sell from Neutral at MKM Partners
01/13/21 Stifel
Stifel says Zoom growth with Phone reminder of 'powerful' enterprise opportunity
01/13/21 Morgan Stanley
Investors have turned too negative on Zoom's persistence, says Morgan Stanley
12/24/20 DA Davidson
DA Davidson likes Zoom push into email, says buy on recent selloff
HLIO Helios Technologies
$67.14 /

+1.295 (+1.97%)

10/12/20 Baird
Helios Technologies upgraded to Outperform from Neutral at Baird
05/29/20 Morgan Stanley
Morgan Stanley upgrades Helios to Equal Weight following underperformance
05/29/20 Morgan Stanley
Helios Technologies upgraded to Equal Weight from Underweight at Morgan Stanley
03/27/20 Truist
Helios Technologies price target lowered to $36 from $45 at SunTrust
AMRC Ameresco
$60.46 /

+3.18 (+5.55%)

02/09/21 B. Riley
Ameresco price target raised to $72 from $50 at B. Riley Securities
01/26/21 Craig-Hallum
Ameresco price target raised to $75 from $50 at Craig-Hallum
11/03/20 Craig-Hallum
Ameresco price target raised to $50 from $38 at Craig-Hallum
11/03/20 B. Riley
Ameresco price target raised to $50 from $48 at B. Riley Securities
TMDX TransMedics
$36.30 /

+0.33 (+0.92%)

02/24/21 Cowen
TransMedics price target raised to $44 from $20 at Cowen
10/08/20
Fly Intel: Top five analyst downgrades
10/08/20 JPMorgan
TransMedics downgraded to Neutral on 'missed' execution at JPMorgan
10/08/20 JPMorgan
TransMedics downgraded to Neutral from Overweight at JPMorgan
MREO Mereo BioPharma
$3.96 /

+0.07 (+1.80%)

ROKU Roku
$420.23 /

+25.095 (+6.35%)

02/22/21 Needham
Roku price target raised to $550 from $400 at Needham
02/19/21 Truist
Roku price target raised to $480 from $390 at Truist
02/19/21 JPMorgan
Roku price target raised to $525 from $475 at JPMorgan
02/19/21 Oppenheimer
Roku price target raised to $500 from $260 at Oppenheimer
NLSN Nielsen
$23.15 /

+0.73 (+3.26%)

03/01/21 Truist
Nielsen price target raised to $26 from $20 at Truist
01/28/21 Citi
Nielsen price target raised to $27 from $22 at Citi
11/03/20 Deutsche Bank
Nielsen price target lowered to $18 from $22 at Deutsche Bank
08/25/20 Truist
Nielsen price target lowered to $20 from $23 at Truist
FGEN FibroGen
$50.35 /

+0.38 (+0.76%)

02/01/21 H.C. Wainwright
FibroGen initiated with a Buy at H.C. Wainwright
12/21/20 Mizuho
FibroGen should be bought on PDUFA extension weakness, says Mizuho
10/26/20 Raymond James
FibroGen initiated with an Underperform at Raymond James
10/26/20 Raymond James
FibroGen initiated with an Underperform at Raymond James
AI C3.ai
$120.78 /

+8.41 (+7.48%)

01/04/21 KeyBanc
C3.ai initiated with a Sector Weight at KeyBanc
01/04/21 Wedbush
Wedbush bullish on C3.ai, initiates with an Outperform
01/04/21 Canaccord
C3.ai initiated with a Hold at Canaccord
01/04/21 Morgan Stanley
C3.ai initiated with an Underweight at Morgan Stanley
INSG Inseego
$15.00 /

+0.35 (+2.39%)

02/17/21 Cowen
Inseego price target raised to $20 from $17 at Cowen
09/04/20 Stifel
Inseego 5G opportunity highlighted in meetings with management, says Stifel
08/06/20
Fly Intel: Top five analyst downgrades
08/06/20 Lake Street
Inseego price target raised to $17 from $13 at Lake Street
LMND Lemonade
$132.23 /

+6.5 (+5.17%)

01/21/21 Piper Sandler
Lemonade price target raised to $163 from $105 at Piper Sandler
11/23/20 Morgan Stanley
Root initiated with an Equal Weight at Morgan Stanley
11/12/20 Piper Sandler
Lemonade price target raised to $71 from $63 at Piper Sandler
11/02/20 Piper Sandler
Lemonade initiated with an Overweight at Piper Sandler
MORF Morphic
$84.57 /

+48.64 (+135.37%)

03/01/21 Wells Fargo
Morphic Holding price target raised to $103 from $40 at Wells Fargo
02/02/21 RBC Capital
Morphic Holding price target raised to $50 from $35 at RBC Capital
10/26/20 RBC Capital
Morphic Holding initiated with an Outperform at RBC Capital
08/11/20 BMO Capital
Morphic Holding price target raised to $37 from $30 at BMO Capital
SCPL SciPlay
$19.28 /

+1.07 (+5.88%)

02/18/21 Deutsche Bank
SciPlay price target raised to $23 from $20 at Deutsche Bank
02/17/21 BofA
SciPlay double-downgraded to Underperform from Buy at BofA
12/22/20 Morgan Stanley
SciPlay price target raised to $16 from $15 at Morgan Stanley
12/16/20 JPMorgan
SciPlay downgraded to Neutral on tough comps at JPMorgan
NIO NIO
$49.79 /

+3.08 (+6.59%)

02/26/21 HSBC
NIO price target raised to $54 from $44.70 at HSBC
02/09/21 Deutsche Bank
NIO job post shows ambitions to enter U.S. market, says Deutsche Bank
01/28/21 Morgan Stanley
NIO price target raised to $80 from $33 at Morgan Stanley
01/22/21
Fly Intel: Top five analyst initiations
SWCH Switch
$17.69 /

+0.33 (+1.90%)

02/02/21
Truist sees Switch positioned for long-term growth, starts at Buy
02/02/21 Truist
Switch initiated with a Buy at Truist
01/13/21 Jefferies
Switch upgraded to Buy on earnings growth inflection at Jefferies
01/13/21 Jefferies
Switch upgraded to Buy from Hold at Jefferies
NVAX Novavax
$239.73 /

+8.52 (+3.68%)

02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/22/21 Cantor Fitzgerald
Cantor says PREVENT-19 gives Novavax potential for differentiated analyses
02/22/21 B. Riley
B. Riley reiterates Buy rating on Novavax as PREVENT-19 enrollment wraps up
02/18/21 B. Riley
Novavax price target raised to $397 from $334 at B. Riley Securities
SRPT Sarepta
$86.94 /

-0.07 (-0.08%)

02/26/21 Mizuho
Sarepta price target raised to $160 from $158 at Mizuho
02/25/21 Piper Sandler
Piper says Sarepta's Amondys 45 approval comes with 'relatively clean label'
02/09/21 Morgan Stanley
Sarepta denied motion to dismiss 'Wilson Wolf' case, says Morgan Stanley
01/12/21 Citi
Sarepta downgraded to Neutral from Buy at Citi
SILK Silk Road Medical
$55.35 /

+0.53 (+0.97%)

02/04/21 Piper Sandler
Silk Road recall update 'should be received positively,' says Piper Sandler
01/25/21 Piper Sandler
Silk Road Medical recall primarily manufacturing related, says Piper Sandler
01/13/21 Piper Sandler
Piper Sandler sees no 'larger issue in play' following Silk Road Medical recall
11/11/20 Piper Sandler
Silk Road Medical price target raised to $58 from $54 at Piper Sandler
OSUR OraSure
$11.08 /

+0.42 (+3.94%)

12/22/20 Lake Street
Lake Street says OraSure test news disappointing, not due to fundamental issues
08/21/20
Fly Intel: Top five analyst initiations
08/21/20 Evercore ISI
OraSure initiated with an Outperform at Evercore ISI
08/21/20 Evercore ISI
OraSure initiated with an Outperform at Evercore ISI
APPF AppFolio
$160.72 /

-4.985 (-3.01%)

02/25/21 DA Davidson
AppFolio price target raised to $126 from $110 at DA Davidson
01/25/21 Stephens
AppFolio initiated with an Underweight at Stephens
01/25/21 Stephens
AppFolio initiated with an Underweight at Stephens
10/26/20 Keefe Bruyette
AppFolio initiated with a Market Perform at Keefe Bruyette
SGMS Scientific Games
$50.79 /

+3.84 (+8.18%)

02/09/21 Craig-Hallum
Scientific Games Digital segment still 'underappreciated,' says Craig-Hallum
01/19/21 Jefferies
Scientific Games price target raised to $55 from $50 at Jefferies
01/14/21 Truist
Scientific Games price target raised to $60 from $45 at Truist
01/14/21 Craig-Hallum
Dec. NJ gaming data caps off year of significant growth, says Craig-Hallum
MELI MercadoLibre
$1,715.90 /

+80.81 (+4.94%)

03/01/21 Credit Suisse
MercadoLibre price target raised to $1,925 from $1,555 at Credit Suisse
02/11/21
Fly Intel: Top five analyst initiations
02/11/21 Scotiabank
Scotiabank starts MercadoLibre at neutral, awaits better entry point
02/11/21 Scotiabank
MercadoLibre initiated with a Sector Perform at Scotiabank
RDHL RedHill Biopharma
$9.19 /

-0.33 (-3.47%)

11/12/20 Roth Capital
RedHill Biopharma price target lowered to $12 from $16 at Roth Capital
09/11/20 BTIG
RedHill Biopharma initiated with a Buy at BTIG
08/14/20 Roth Capital
Roth Capital maintains Buy on RedHill after 'noisy' quarter
07/07/20 SMBC Nikko
RedHill Biopharma initiated with an Outperform at SMBC Nikko
COHU Cohu
$46.01 /

+2.46 (+5.65%)

02/12/21 Craig-Hallum
Cohu price target raised to $73 from $45 at Craig-Hallum
02/12/21 B. Riley
Cohu price target raised to $72 from $60 at B. Riley Securities
02/10/21 B. Riley
B. Riley Securities sees interesting opportunities in Skyworks, Silicon Motion
01/25/21 B. Riley
Cohu price target raised to $60 from $46 at B. Riley Securities
BYND Beyond Meat
$147.09 /

+1.7 (+1.17%)

03/01/21 DA Davidson
Beyond Meat price target raised to $145 from $133 at DA Davidson
02/26/21 Piper Sandler
Beyond Meat relationship with McDonald's not much changed, says Piper Sandler
02/26/21 UBS
Beyond Meat price target raised to $130 from $107 at UBS
02/26/21 Goldman Sachs
Beyond Meat price target raised to $112 from $105 at Goldman Sachs
ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

TTEC TTEC Holdings
$88.80 /

+4.49 (+5.33%)

TMDX TransMedics
$36.30 /

+0.33 (+0.92%)

SWCH Switch
$17.69 /

+0.33 (+1.90%)

SRPT Sarepta
$86.94 /

-0.07 (-0.08%)

SILK Silk Road Medical
$55.35 /

+0.53 (+0.97%)

SGMS Scientific Games
$50.79 /

+3.84 (+8.18%)

SCPL SciPlay
$19.28 /

+1.07 (+5.88%)

ROKU Roku
$420.23 /

+25.095 (+6.35%)

RDHL RedHill Biopharma
$9.19 /

-0.33 (-3.47%)

OSUR OraSure
$11.08 /

+0.42 (+3.94%)

NVAX Novavax
$239.73 /

+8.52 (+3.68%)

NLSN Nielsen
$23.15 /

+0.73 (+3.26%)

NIO NIO
$49.79 /

+3.08 (+6.59%)

MREO Mereo BioPharma
$3.96 /

+0.07 (+1.80%)

MORF Morphic
$84.57 /

+48.64 (+135.37%)

MELI MercadoLibre
$1,715.90 /

+80.81 (+4.94%)

LMND Lemonade
$132.23 /

+6.5 (+5.17%)

INSG Inseego
$15.00 /

+0.35 (+2.39%)

INO Inovio
$11.64 /

+0.52 (+4.68%)

HLIO Helios Technologies
$67.14 /

+1.295 (+1.97%)

FGEN FibroGen
$50.35 /

+0.38 (+0.76%)

COHU Cohu
$46.01 /

+2.46 (+5.65%)

BYND Beyond Meat
$147.09 /

+1.7 (+1.17%)

ASLN Aslan Pharmaceuticals
$5.22 /

+0.82 (+18.64%)

APPF AppFolio
$160.72 /

-4.985 (-3.01%)

AMRC Ameresco
$60.46 /

+3.18 (+5.55%)

AI C3.ai
$120.78 /

+8.41 (+7.48%)

  • 03
    Mar
  • 04
    Mar
  • 03
    Mar
  • 02
    Mar
  • 10
    Feb
  • 21
    Jan
  • 13
    Jan
  • 14
    Jan
  • 14
    Dec
  • 09
    Dec
  • 31
    Aug
  • 02
    Jul
  • 11
    Jun
  • 03
    Jun
  • 27
    May
  • 06
    May
  • 17
    Mar
ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

SGMS Scientific Games
$50.79 /

+3.84 (+8.18%)

ROKU Roku
$420.23 /

+25.095 (+6.35%)

NVAX Novavax
$239.73 /

+8.52 (+3.68%)

NLSN Nielsen
$23.15 /

+0.73 (+3.26%)

NIO NIO
$49.79 /

+3.08 (+6.59%)

LMND Lemonade
$132.23 /

+6.5 (+5.17%)

INSG Inseego
$15.00 /

+0.35 (+2.39%)

INO Inovio
$11.64 /

+0.52 (+4.68%)

BYND Beyond Meat
$147.09 /

+1.7 (+1.17%)

ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

SRPT Sarepta
$86.94 /

-0.07 (-0.08%)

SGMS Scientific Games
$50.79 /

+3.84 (+8.18%)

ROKU Roku
$420.23 /

+25.095 (+6.35%)

OSUR OraSure
$11.08 /

+0.42 (+3.94%)

NVAX Novavax
$239.73 /

+8.52 (+3.68%)

NLSN Nielsen
$23.15 /

+0.73 (+3.26%)

NIO NIO
$49.79 /

+3.08 (+6.59%)

MORF Morphic
$84.57 /

+48.64 (+135.37%)

LMND Lemonade
$132.23 /

+6.5 (+5.17%)

INSG Inseego
$15.00 /

+0.35 (+2.39%)

INO Inovio
$11.64 /

+0.52 (+4.68%)

FGEN FibroGen
$50.35 /

+0.38 (+0.76%)

COHU Cohu
$46.01 /

+2.46 (+5.65%)

BYND Beyond Meat
$147.09 /

+1.7 (+1.17%)

AI C3.ai
$120.78 /

+8.41 (+7.48%)

ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

TMDX TransMedics
$36.30 /

+0.33 (+0.92%)

ROKU Roku
$420.23 /

+25.095 (+6.35%)

OSUR OraSure
$11.08 /

+0.42 (+3.94%)

NVAX Novavax
$239.73 /

+8.52 (+3.68%)

NLSN Nielsen
$23.15 /

+0.73 (+3.26%)

NIO NIO
$49.79 /

+3.08 (+6.59%)

LMND Lemonade
$132.23 /

+6.5 (+5.17%)

INSG Inseego
$15.00 /

+0.35 (+2.39%)

INO Inovio
$11.64 /

+0.52 (+4.68%)

FGEN FibroGen
$50.35 /

+0.38 (+0.76%)

BYND Beyond Meat
$147.09 /

+1.7 (+1.17%)

AI C3.ai
$120.78 /

+8.41 (+7.48%)

Earnings
SciPlay reports Q4 EPS 18c, consensus 26c » 16:03
03/01/21
03/01
16:03
03/01/21
16:03
SCPL

SciPlay

$19.30 /

+1.09 (+5.99%)

Reports Q4 revenue…

Reports Q4 revenue $147.1M, consensus $146.11M.

ShowHide Related Items >><<
SCPL SciPlay
$19.30 /

+1.09 (+5.99%)

SCPL SciPlay
$19.30 /

+1.09 (+5.99%)

02/18/21 Deutsche Bank
SciPlay price target raised to $23 from $20 at Deutsche Bank
02/17/21 BofA
SciPlay double-downgraded to Underperform from Buy at BofA
12/22/20 Morgan Stanley
SciPlay price target raised to $16 from $15 at Morgan Stanley
12/16/20 JPMorgan
SciPlay downgraded to Neutral on tough comps at JPMorgan
SCPL SciPlay
$19.30 /

+1.09 (+5.99%)

Recommendations
SciPlay price target raised to $23 from $20 at Deutsche Bank » 07:10
02/18/21
02/18
07:10
02/18/21
07:10
SCPL

SciPlay

$19.42 /

-1.24 (-6.00%)

Deutsche Bank analyst…

Deutsche Bank analyst Bryan Kraft raised the firm's price target on SciPlay to $23 from $20 and keeps a Buy rating on the shares. The analyst believes SciPlay's top games were "roughly stable in aggregate" during Q4.

ShowHide Related Items >><<
SCPL SciPlay
$19.42 /

-1.24 (-6.00%)

SCPL SciPlay
$19.42 /

-1.24 (-6.00%)

02/17/21 BofA
SciPlay double-downgraded to Underperform from Buy at BofA
12/22/20 Morgan Stanley
SciPlay price target raised to $16 from $15 at Morgan Stanley
12/16/20 JPMorgan
SciPlay downgraded to Neutral on tough comps at JPMorgan
12/16/20 JPMorgan
SciPlay downgraded to Neutral from Overweight at JPMorgan
SCPL SciPlay
$19.42 /

-1.24 (-6.00%)

Downgrade
SciPlay double-downgraded to Underperform from Buy at BofA » 06:20
02/17/21
02/17
06:20
02/17/21
06:20
SCPL

SciPlay

$20.66 /

+0.16 (+0.78%)

BofA analyst Ryan Gee…

BofA analyst Ryan Gee double-downgraded SciPlay to Underperform from Buy with a price target of $20, up from $17. After a 46% year-to-date run up in the stock price, the analyst sees better relative returns elsewhere in his mobile games coverage, adding that he is also relatively less optimistic on SciPlay as a content aggregator vs. peers and cautious on the sustainability of its growth via new games and user-acquisition.

ShowHide Related Items >><<
SCPL SciPlay
$20.66 /

+0.16 (+0.78%)

SCPL SciPlay
$20.66 /

+0.16 (+0.78%)

12/22/20 Morgan Stanley
SciPlay price target raised to $16 from $15 at Morgan Stanley
12/16/20 JPMorgan
SciPlay downgraded to Neutral on tough comps at JPMorgan
12/16/20 JPMorgan
SciPlay downgraded to Neutral from Overweight at JPMorgan
SCPL SciPlay
$20.66 /

+0.16 (+0.78%)

Over a quarter ago
Recommendations
SciPlay price target raised to $16 from $15 at Morgan Stanley » 08:12
12/22/20
12/22
08:12
12/22/20
08:12
SCPL

SciPlay

$14.83 /

+0.07 (+0.47%)

Morgan Stanley analyst…

Morgan Stanley analyst Matthew Cost raised the firm's price target on SciPlay (SCPL) to $16 from $15 and keeps an Equal Weight rating on the shares. The firm's work shows 2020 likely pulled forward about four years of video game user growth, said Cost and peer Brian Nowak, who think it will be increasingly important for publishers to keep their content fresh to "keep these players and their wallets as the real world reopens." They identify Activision Blizzard (ATVI), Take-Two (TTWO) and Zynga as their top picks in the game publishing space.

ShowHide Related Items >><<
SCPL SciPlay
$14.83 /

+0.07 (+0.47%)

SCPL SciPlay
$14.83 /

+0.07 (+0.47%)

12/16/20 JPMorgan
SciPlay downgraded to Neutral on tough comps at JPMorgan
12/16/20 JPMorgan
SciPlay downgraded to Neutral from Overweight at JPMorgan
11/30/20 KeyBanc
SciPlay initiated with an Overweight at KeyBanc
11/05/20 BofA
SciPlay upgraded to Buy on turnaround momentum at BofA
SCPL SciPlay
$14.83 /

+0.07 (+0.47%)

SCPL SciPlay
$14.83 /

+0.07 (+0.47%)

Downgrade
SciPlay downgraded to Neutral on tough comps at JPMorgan » 06:17
12/16/20
12/16
06:17
12/16/20
06:17
SCPL

SciPlay

$14.75 /

+0.17 (+1.17%)

JPMorgan analyst Alexia…

JPMorgan analyst Alexia Quadrani downgraded SciPlay to Neutral from Overweight with a price target of $15, down from $19. The company has outperformed in 2020 due to COVID-19 benefits, but slots-based games are particularly at risk for a difficult comp following the broad distribution of a vaccine, Quadrani tells investors in a research note. Further, SciPlay's Solitaire Pets: Adventure game will take time to ramp with the beta mode launching in early 2021, says the analyst.

ShowHide Related Items >><<
SCPL SciPlay
$14.75 /

+0.17 (+1.17%)

SCPL SciPlay
$14.75 /

+0.17 (+1.17%)

12/16/20 JPMorgan
SciPlay downgraded to Neutral from Overweight at JPMorgan
11/30/20 KeyBanc
SciPlay initiated with an Overweight at KeyBanc
11/05/20 BofA
SciPlay upgraded to Buy on turnaround momentum at BofA
11/05/20 BofA
SciPlay upgraded to Buy from Neutral at BofA
SCPL SciPlay
$14.75 /

+0.17 (+1.17%)

SCPL SciPlay
$14.75 /

+0.17 (+1.17%)

Downgrade
SciPlay downgraded to Neutral from Overweight at JPMorgan » 04:49
12/16/20
12/16
04:49
12/16/20
04:49
SCPL

SciPlay

$14.75 /

+0.17 (+1.17%)

JPMorgan analyst Alexia…

JPMorgan analyst Alexia Quadrani downgraded SciPlay to Neutral from Overweight with a $15 price target.

ShowHide Related Items >><<
SCPL SciPlay
$14.75 /

+0.17 (+1.17%)

SCPL SciPlay
$14.75 /

+0.17 (+1.17%)

11/30/20 KeyBanc
SciPlay initiated with an Overweight at KeyBanc
11/05/20 BofA
SciPlay upgraded to Buy on turnaround momentum at BofA
11/05/20 BofA
SciPlay upgraded to Buy from Neutral at BofA
08/31/20 Jefferies
After recent filing, Jefferies says 'something happening' at Scientific Games
SCPL SciPlay
$14.75 /

+0.17 (+1.17%)

SCPL SciPlay
$14.75 /

+0.17 (+1.17%)

Initiation
SciPlay initiated with an Overweight at KeyBanc » 06:13
11/30/20
11/30
06:13
11/30/20
06:13
SCPL

SciPlay

$14.66 /

+0.07 (+0.48%)

KeyBanc analyst Tyler…

KeyBanc analyst Tyler Parker initiated coverage of SciPlay with an Overweight rating and $18 price target. The company trades at a discount to the broader mobile gaming group even though it has consistently grown revenue while expanding adjusted EBITDA margins from 19% to 33%, Parker tells investors in a research note. He believes there are "meaningful opportunities" to drive growth within SciPlay's core portfolio, via expansion into the casual genre, and with international penetration.

ShowHide Related Items >><<
SCPL SciPlay
$14.66 /

+0.07 (+0.48%)

SCPL SciPlay
$14.66 /

+0.07 (+0.48%)

11/05/20 BofA
SciPlay upgraded to Buy on turnaround momentum at BofA
11/05/20 BofA
SciPlay upgraded to Buy from Neutral at BofA
08/31/20 Jefferies
After recent filing, Jefferies says 'something happening' at Scientific Games
06/22/20 Truist
SciPlay acquisition consistent with strategy, says SunTrust
SCPL SciPlay
$14.66 /

+0.07 (+0.48%)

SCPL SciPlay
$14.66 /

+0.07 (+0.48%)

Upgrade
SciPlay upgraded to Buy on turnaround momentum at BofA » 10:28
11/05/20
11/05
10:28
11/05/20
10:28
SCPL

SciPlay

$13.58 /

-0.52 (-3.69%)

As previously reported,…

As previously reported, BofA analyst Ryan Gee upgraded SciPlay to Buy from Neutral with a price target of $17, up from $16 after the company reported better than expected bookings that were driven by double-digit growth in payers and revenue per payer. Revenue growth above the category and stable payers quarter-over-quarter despite a sharp decline in players were what stood out most to him in the report, said Gee, who sees these results as evidence of a renewed focus on higher value users that are more-likely to convert to payers, success in re-activating lapsed payers, and recent changes to its game teams to bolster the content pipeline, the analyst tells investors. The "strong" Q3 results have convinced him that the recent momentum is more structural and, therefore, likely to persist beyond any "normalization," the analyst added.

ShowHide Related Items >><<
SCPL SciPlay
$13.58 /

-0.52 (-3.69%)

SCPL SciPlay
$13.58 /

-0.52 (-3.69%)

11/05/20 BofA
SciPlay upgraded to Buy from Neutral at BofA
08/31/20 Jefferies
After recent filing, Jefferies says 'something happening' at Scientific Games
06/22/20 Truist
SciPlay acquisition consistent with strategy, says SunTrust
06/10/20 RBC Capital
SciPlay downgraded to Sector Perform from Outperform at RBC Capital
SCPL SciPlay
$13.58 /

-0.52 (-3.69%)

SCPL SciPlay
$13.58 /

-0.52 (-3.69%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.